Search Results 2521-2530 of 18288 for rheumatoid arthritis

  1. Antiphospholipid syndrome - Doctors and departments - Mayo Clinic

    Rheumatology · Vascular centers. Areas that research this condition. Neurology Research · By Mayo Clinic Staff · Request an appointment · Diagnosis & treatment.

  2. ATHN 9: Severe Von Willebrand Disease Natural History Study - Mayo Clinic

    The purpose of this study is to assess the safety of various Von Willebrand Factor (VWF) regimens for different indications (on-demand, surgery and prophylaxis) ...

  3. Back Pain Clinical Trials - Mayo Clinic Research

    Spinal cord stimulation (SCS) has been used for almost 30 years to treat many intractable back pain conditions. It has demonstrated efficacy in the co-called ...

  4. Study Of SX-682 Alone And In Combination With Oral Or Intravenous Decitabine In Subjects With Myelodysplastic Syndrome - Mayo Clinic

    * Use of erythroid stimulating agents, Granulocyte-colony stimulating factor (G-CSF), or Granulocyte-macrophage colony-stimulating factor (GM-CSF) within 14 ...

  5. Publications - Deb A. Baumgarten, M.D., M.P.H. - Mayo Clinic

    Ramucirumab and Docetaxel in Patients with Metastatic Urothelial Carcinoma Harboring Fibroblast Growth Factor Receptor Alterations: A Case Series and Literature ...

  6. Publications - Benjamin M. Howe, M.D. - Mayo Clinic

    ... arthritis. Emerg Radiol. 2024 Aug; 31 (4):491-497 Epub 2024 June 07. View PubMed; Maldonado AA, Marek T, Howe BM, Broski SM, Carter JM, Spinner RJ ...

  7. Spinal arteriovenous malformation (AVM) - Doctors and departments - Mayo Clinic

    ... arthritis. Show more areas of focus for Chris C. Fox, M.D.. Research. Publications. See a list of publications about spinal arteriovenous malformation (AVM) by ...

  8. Publications - Jeremy C. Jones, M.D. - Mayo Clinic

    Lack of Caudal-Type Homeobox Transcription Factor 2 Expression as a Prognostic Biomarker in Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2017 Jun ...

  9. Specialized care for infected joints - Mayo Clinic

    Mayo manufactures antibiotic spacers at the time of surgery. This individualized approach enhances mobility while medication clears the infection.

  10. Publications - Paschalis Vergidis, M.D., M.S. - Mayo Clinic

    Histoplasmosis complicating tumor necrosis factor-alpha blocker therapy: a retrospective analysis of 98 cases. Clin Infect Dis. 2015 Aug 1; 61 (3):409-17 ...